Adding intravenous thrombolysis to endovascular treatment is not associated with an increased risk for bleeding or with changes in functional outcomes in patients with carotid tandem lesions.

In the Phase III EXPECTS trial, patients experiencing mostly mild posterior circulation ischemic stroke who were ineligible ...

Although the administration method seems ideal for prehospital use, the complexities of stroke assessment — including CT imaging and neurologist evaluation — still limit EMS adoption. Mechanical ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

For patients with mainly mild posterior circulation ischemic stroke who do not receive thrombectomy, alteplase administered ...

Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.

Download a PDF of the Research Summary. A total of 234 patients were enrolled; 117 were assigned to the alteplase group and 117 to the standard treatment group. The median score on the National ...

Researchers saw no significant difference between tenecteplase and alteplase in terms of effectiveness or safety outcomes, including functional independence at discharge. HealthDay News — For patients ...

Data were included for 79,550 patients treated with intravenous thrombolysis, of whom 11.9 and 88.1 percent received tenecteplase and alteplase, respectively. The researchers observed no ...